Cenra Inc. (TPE:3716)

Market Cap	5.52B
Revenue (ttm)	8.92B
Net Income (ttm)	317.35M
Shares Out	148.51M
EPS (ttm)	2.48
PE Ratio	14.98
Forward PE	n/a
Dividend	1.00 (2.69%)
Ex-Dividend Date	n/a

Volume	311,859
Average Volume	136,583
Open	36.55
Previous Close	36.40
Day's Range	36.30 - 37.30
52-Week Range	29.00 - 44.55
Beta	n/a
RSI	64.25
Earnings Date	May 13, 2025

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands. In a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1952
• Employees: 542
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3716

Financial Performance

In 2024, Cenra's revenue was 8.92 billion, an increase of 4.01% compared to the previous year's 8.57 billion. Earnings were 317.35 million, a decrease of -1.53%.